Snowden Capital Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Buy |
5,635
+674
| +14% | +$61.6K | 0.02% | 751 |
|
|
2025
Q1 | $563K | Buy |
4,961
+99
| +2% | +$11.2K | 0.02% | 690 |
|
|
2024
Q4 | $515K | Buy |
4,862
+2,227
| +85% | +$236K | 0.02% | 761 |
|
|
2024
Q3 | $285K | Sell |
2,635
-676
| -20% | -$73.1K | 0.01% | 1017 |
|
|
2024
Q2 | $360K | Sell |
3,311
-369
| -10% | -$40.1K | 0.01% | 895 |
|
|
2024
Q1 | $487K | Sell |
3,680
-145
| -4% | -$19.2K | 0.02% | 775 |
|
|
2023
Q4 | $466K | Sell |
3,825
-374
| -9% | -$45.5K | 0.02% | 727 |
|
|
2023
Q3 | $471K | Sell |
4,199
-3,166
| -43% | -$355K | 0.02% | 681 |
|
|
2023
Q2 | $1.07M | Sell |
7,365
-825
| -10% | -$120K | 0.04% | 441 |
|
|
2023
Q1 | $1.06M | Buy |
8,190
+18
| +0.2% | +$2.33K | 0.04% | 444 |
|
|
2022
Q4 | $1.04M | Buy |
8,172
+750
| +10% | +$95.6K | 0.04% | 440 |
|
|
2022
Q3 | $775K | Buy |
7,422
+1,620
| +28% | +$169K | 0.04% | 493 |
|
|
2022
Q2 | $609K | Buy |
5,802
+768
| +15% | +$80.6K | 0.03% | 553 |
|
|
2022
Q1 | $643K | Buy |
5,034
+3,613
| +254% | +$461K | 0.03% | 548 |
|
|
2021
Q4 | $175K | Sell |
1,421
-1,461
| -51% | -$180K | 0.01% | 696 |
|
|
2021
Q3 | $410K | Buy |
2,882
+57
| +2% | +$8.1K | 0.02% | 589 |
|
|
2021
Q2 | $441K | Buy |
2,825
+29
| +1% | +$4.53K | 0.02% | 579 |
|
|
2021
Q1 | $435K | Buy |
2,796
+1,245
| +80% | +$194K | 0.02% | 526 |
|
|
2020
Q4 | $232K | Buy |
+1,551
| New | +$232K | 0.02% | 593 |
|